192 related articles for article (PubMed ID: 31040160)
1. Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome.
Day SM; Yang W; Wang X; Stern JE; Zhou X; Macauley SL; Ma T
eNeuro; 2019; 6(2):. PubMed ID: 31040160
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 cleavage product GLP-1 (9-36) amide enhances hippocampal long-term synaptic plasticity in correlation with suppression of Kv4.2 expression and eEF2 phosphorylation.
Day SM; Yang W; Ewin S; Zhou X; Ma T
Hippocampus; 2017 Dec; 27(12):1264-1274. PubMed ID: 28833775
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide rescues synaptic plasticity and memory deficits in Alzheimer's disease model mice.
Ma T; Du X; Pick JE; Sui G; Brownlee M; Klann E
J Neurosci; 2012 Oct; 32(40):13701-8. PubMed ID: 23035082
[TBL] [Abstract][Full Text] [Related]
4. A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice.
Wang ZJ; Han YF; Zhao F; Yang GZ; Yuan L; Cai HY; Yang JT; Holscher C; Qi JS; Wu MN
Horm Behav; 2020 Feb; 118():104640. PubMed ID: 31765661
[TBL] [Abstract][Full Text] [Related]
5. Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice.
Porter D; Faivre E; Flatt PR; Hölscher C; Gault VA
Peptides; 2012 May; 35(1):1-8. PubMed ID: 22465882
[TBL] [Abstract][Full Text] [Related]
6. A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease.
Li T; Jiao JJ; Hölscher C; Wu MN; Zhang J; Tong JQ; Dong XF; Qu XS; Cao Y; Cai HY; Su Q; Qi JS
Hippocampus; 2018 May; 28(5):358-372. PubMed ID: 29473979
[TBL] [Abstract][Full Text] [Related]
7. GLP-1 analogue CJC-1131 prevents amyloid β protein-induced impirments of spatial memory and synaptic plasticity in rats.
Zhang SX; Cai HY; Ma XW; Yuan L; Zhang J; Wang ZJ; Li YF; Qi JS
Behav Brain Res; 2017 May; 326():237-243. PubMed ID: 28315374
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice.
Yan XD; Qu XS; Yin J; Qiao J; Zhang J; Qi JS; Wu MN
J Alzheimers Dis; 2022; 85(1):343-357. PubMed ID: 34806605
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin restores BDNF-LTP and the persistence of long-term memory in a model of Down's syndrome.
Andrade-Talavera Y; Benito I; Casañas JJ; Rodríguez-Moreno A; Montesinos ML
Neurobiol Dis; 2015 Oct; 82():516-525. PubMed ID: 26388397
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease.
McClean PL; Gault VA; Harriott P; Hölscher C
Eur J Pharmacol; 2010 Mar; 630(1-3):158-62. PubMed ID: 20035739
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice.
Lennox R; Porter DW; Flatt PR; Holscher C; Irwin N; Gault VA
Neuropharmacology; 2014 Nov; 86():22-30. PubMed ID: 24998752
[TBL] [Abstract][Full Text] [Related]
12. Grape Seed Proanthocyanidin Extract Ameliorates Streptozotocin-induced Cognitive and Synaptic Plasticity Deficits by Inhibiting Oxidative Stress and Preserving AKT and ERK Activities.
Gao WL; Li XH; Dun XP; Jing XK; Yang K; Li YK
Curr Med Sci; 2020 Jun; 40(3):434-443. PubMed ID: 32681248
[TBL] [Abstract][Full Text] [Related]
13. DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.
Cao Y; Hölscher C; Hu MM; Wang T; Zhao F; Bai Y; Zhang J; Wu MN; Qi JS
Eur J Pharmacol; 2018 May; 827():215-226. PubMed ID: 29551659
[TBL] [Abstract][Full Text] [Related]
14. Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome.
Corrales A; Vidal R; García S; Vidal V; Martínez P; García E; Flórez J; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
J Pineal Res; 2014 Jan; 56(1):51-61. PubMed ID: 24147912
[TBL] [Abstract][Full Text] [Related]
15. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
16. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
[TBL] [Abstract][Full Text] [Related]
17. Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome.
Parisotto EB; Vidal V; García-Cerro S; Lantigua S; Wilhelm Filho D; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
Neurochem Res; 2016 Nov; 41(11):2904-2913. PubMed ID: 27450081
[TBL] [Abstract][Full Text] [Related]
18. Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice.
Gengler S; McClean PL; McCurtin R; Gault VA; Hölscher C
Neurobiol Aging; 2012 Feb; 33(2):265-76. PubMed ID: 20359773
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice.
Porter WD; Flatt PR; Hölscher C; Gault VA
Int J Obes (Lond); 2013 May; 37(5):678-84. PubMed ID: 22665137
[TBL] [Abstract][Full Text] [Related]
20. L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurite pathology in Alzheimer's disease mouse model and cultured hippocampal neurons.
Huang L; Lan J; Tang J; Kang Y; Feng X; Wu L; Peng Y
Mol Neurobiol; 2021 Mar; 58(3):1260-1274. PubMed ID: 33146400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
